Anzeige
Mehr »
Dienstag, 15.07.2025 - Börsentäglich über 12.000 News
Diese Aktie zeigt die wissenschaftliche Schlagkraft hinter ihrer KI-gesteuerten Krebsforschung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NEYG | ISIN: US30211M1036 | Ticker-Symbol: N/A
1-Jahres-Chart
EXOUSIA ADVANCED MATERIALS INC Chart 1 Jahr
5-Tage-Chart
EXOUSIA ADVANCED MATERIALS INC 5-Tage-Chart

Aktuelle News zur EXOUSIA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.06.Marijuana Inc.: Exousia Pro Files Reg A.186ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of...
► Artikel lesen
18.06.Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board427Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company...
► Artikel lesen
30.04.Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant234Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage...
► Artikel lesen
29.04.Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application244- Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based...
► Artikel lesen
21.04.Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview297A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,...
► Artikel lesen
17.04.Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions278ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is...
► Artikel lesen
08.04.Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show261Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company...
► Artikel lesen
EXOUSIA Aktie jetzt für 0€ handeln
03.04.Marijuana Inc.: Exousia Pro Issues Update on Name Change236ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases...
► Artikel lesen
02.04.Marijuana Inc.: Exousia Pro Has Appointed Matthew Dwyer As Its New President265ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,...
► Artikel lesen
01.04.Marijuana Inc.: Exousia Pro Issues and Update on its FDA Orphan Drug Status333ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,...
► Artikel lesen
25.03.Marijuana Inc.: Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun758Exousia Pro will be sending out samples to clients expected to place orders ORLANDO, FL / ACCESS Newswire / March 25, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., announces the official...
► Artikel lesen
18.03.Marijuana Inc.: Exousia Has Successfully Renegotiated Its License Agreement360ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1